Characteristics | Number | No. of patients | P value | |
---|---|---|---|---|
circAKT3high | circAKT3low | |||
Age(y) | ||||
 < 60 | 62 | 34 | 28 | 0.283 |
 ≥ 60 | 43 | 19 | 24 |  |
Gender | ||||
 Male | 80 | 37 | 43 | 0.121 |
 Female | 25 | 16 | 9 |  |
Tumor size(cm) | ||||
 < 3.5 | 56 | 21 | 35 | 0.004** |
 ≥ 3.5 | 49 | 32 | 17 |  |
Histological grade | ||||
 Well-moderately | 33 | 11 | 22 | 0.017* |
 Poorly-signet | 72 | 42 | 30 |  |
Clinical stage | ||||
 II | 39 | 13 | 26 | 0.007** |
 III | 66 | 40 | 26 |  |
T classification | ||||
 T1-T2 | 31 | 9 | 22 | 0.004** |
 T3-T4 | 74 | 44 | 30 |  |
N classification | ||||
 N0 | 14 | 5 | 9 | 0.232 |
 N1-N3 | 91 | 48 | 43 |  |
Cisplatin chemosensitivity | ||||
 Sensitive | 92 | 41 | 51 | 0.001** |
 Resistant | 13 | 12 | 1 |  |